The tenascins (Tn) are a family of four glyco-protein members -- tenascin-C (Tn-C), tenascin-R (Tn-R), tenascin-W (Tn-W) and tenascin-X (Tn-X) -- found diversely in the extra-cellular matrix of vertebrate organs ([@R16]; [@R36]). Important functions of Tn have been investigated in developmental cell adhesion modulation and pathological conditions such as wound healing and tumourigenesis ([@R2]; [@R16]; [@R36]). Tn-C and Tn-R are prominent in the nervous system and play a role in the development of neurite outgrowth and postnatal synaptic plasticity ([@R39]; [@R9]; [@R12]). Tn-W is found abundantly in the developing bone and stroma of certain tumours ([@R9]; [@R36]). Tn-X is the first tenascin member shown to be clearly associated with the human connective tissue disorder Ehlers--Danlos syndrome (EDS; [@R8]). Patients with a Tn-X deficiency suffer from skin hyperextensibility, joint hypermobility and poor wound healing ability ([@R6]). These symptoms are caused by the occurrence of abnormal irregular collagen fibres. Tn-X plays a role in collagen fibrillogenesis by directly binding to collagen ([@R24]; [@R27]). Mice with a Tn-X deficiency also showed skin symptoms comparable with those of EDS ([@R24]).

Interestingly, in an analysis of human single nucleotide polymorphisms, Tn-X was reported to be significantly associated with schizophrenia ([@R38]; [@R34]). However, thus far, there have been no neuroanatomical reports on the involvement of Tn-X in schizophrenia. In the mammalian central nervous system (CNS), Tn-X mRNA expression has only been shown in the rat meninges of the olfactory bulb ([@R11]). Recently, we found novel Tn-X localizations in the adult mouse leptomeninges trabecula in the cerebral cortex and in the connective tissue in the lateral ventricle choroid plexus (CP; [@R19]). Our finding of Tn-X localization in CP, which produces cerebrospinal fluid (CSF), might be a key factor in the investigation of the association between CSF metabolism and enlarged ventricles in schizophrenia. Enlarged ventricles are typical structural abnormalities associated with schizophrenia ([@R29]). Furthermore, CP secretes biologically active molecules into the CSF for brain development, activity and protection ([@R30]; [@R4]; [@R33]; [@R20]). In these molecules, for instance, there is a brain-derived neurotrophic factor (BDNF), the gene expression level and polymorphism of which have been analysed in relation to the pathogenesis of schizophrenia ([@R7]). One study reported that BDNF is able to stimulate Tn-X expression in vitro ([@R32]).

The validity and limitations of animal models (rodents and monkeys) for use in the study of schizophrenia have been discussed ([@R35]). The authors concluded that monkeys appear to be an interesting social interaction model, more so than rodents, because of their complex well-organized social structure. In addition to differences in social structure, the dopaminergic system of rats and monkeys is quite different ([@R13]), and dysfunction of the dopaminergic system is related to schizophrenia ([@R37]).

The CSF outflow system has been studied in some animal models ([@R21]). An anatomical difference in arachnoid granulations has been shown between rodents and monkeys ([@R22]). Arachnoid granulations in monkeys are structurally similar to those in humans ([@R10]; [@R22]). In contrast, arachnoid granulations in rodents are similar to those of cats and dogs ([@R22]). It is possible that Tn-X localization in CP is different between rodents and monkeys.

Therefore, details concerning Tn-X localization in monkey CP need to be clarified. In the present study, we compared the immunohistochemistry of Tn-X in monkey CP with that in mouse CP. Subsequently, to verify the reliability of Tn-X localization, we compared it with Tn-C localization in corresponding regions using neighbouring sections.

Materials and Methods {#S1}
=====================

Two male monkeys (*Macaca mulatta*) weighing 3.3 and 8.0 kg and five male ICR mice (11 weeks of age) were used as experimental animals in this study. The monkey tissues were a gift of Dr Kathleen Rockland (RIKEN Brain Science Institute).This study was conducted in accordance with of the official Japanese regulations for research on animals (according to institutionally approved protocols; RIKEN Institute and the Nippon Dental University, approval no. 07-04) and in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication no. 80-23, revised 1996). The animals were perfused with 4% paraformaldehyde in 0.1 M phosphate buffered saline after being deeply anaesthetized with nembutal as previously reported ([@R18]; [@R19]). The monkey CP was carefully dissected from the lateral and fourth ventricles. Mouse brains were removed from the skull. The tissues were rapidly frozen by immersing them in a cold acetone solution with dry ice and were cut transversely or horizontally at 30 µm with a cryostat. We used a previously described immunohistochemical to analyse Tn-X and Tn-C ([@R19]). Briefly, the sections were processed for either Tn-X or Tn-C single immunoperoxidase staining (goat polyclonal anti-Tn-X antibody, catalogue no. sc-5498 or anti-Tn-C antibody, catalogue no. sc-9871; Santa Cruz Biotechnology, Santa Cruz, CA). The sections were incubated for 2 days at 4°C. Finally, the sections were incubated with biotinylated anti-goat secondary rabbit antibody (Vector Laboratories, Burlingame, CA) and visualized using avidin-biotin complex conjugated horseradish peroxidase (ABC Elite kits, Vector Laboratories) with diaminobenzidine. Routine controls for immunostaining were used during these experiments, by omission of the two primary antibodies. Photographs were taken as digital images with a digital camera (VB7010; Keyence, Japan) equipped with a microscope (DM-RE; Leica Microsystems, Germany). The images were adjusted for contrast and/or brightness to match the real image using standard image software (Adobe Photoshop 5.5, Adobe, San Jose, CA).

Results {#S2}
=======

We observed Tn-X and Tn-C localizations in the fourth and lateral ventricles of monkey CP ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}A, B). Tn-X- positive (Tn-X+) fibrous structures were clearly observed in CP ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}A, B) of both ventricles. The Tn-X+ fibrous structures were restricted to the interstitial connective tissue in CP ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}A, B). In neighbouring sections, Tn-X+ fibrous structures were clearly confined to the connective tissue and did not colocalize with Tn-C in CP ([Figure 1](#F1){ref-type="fig"}B, E). Tn-X was notably distributed around the blood vessels in CP. Dense Tn-X+ fibrils surrounded blood vessels in CP ([Figure 2](#F2){ref-type="fig"}A, B). The presence of Tn-X+ and Tn-C+ was confirmed in some blood vessels in the parenchyma of the cerebellum and medulla oblongata ([Figure 2](#F2){ref-type="fig"}C, E). These results were consistent with previous reports of vascular localization of Tn-X and Tn-C ([@R26]; [@R15]; [@R3]). In addition, a leptomeningeal Tn-X+ trabecular structure was also observed in the cerebellum ([Figure 2](#F2){ref-type="fig"}C). In contrast, no leptomeningeal localization of Tn-C was detected ([Figure 2](#F2){ref-type="fig"}D). The Tn-X+ trabecula might correspond to the leptomeninges trabecula in the subarachnoid space ([@R14]; [@R19]). These observations in monkeys were similar to those of our previous findings of Tn-X localization in mouse CP of lateral ventricles and leptomeninges ([@R19]).

Figure 1Immunohistochemistry (IHC) of tenascin-X (Tn-X) and tenascin-C (Tn-C) in monkey choroid plexus (CP) in fourth ventricle. (A) Low magnification of IHC of Tn-X in the lateral recess of fourth ventricle. Two boxed regions are re-photographed at higher magnification in B and D. (B, D) Tn-X positive fibrous structures are clearly observed within connective tissue of CP (arrows). (C, E) IHC of the Tn-C in neighboring sections to the B and D. Tn-C positive fibrous structures are not detected within the connective tissue of CP. CC: cerebellar cortex, EC: epithelial cell, MO: medulla oblongata. Scale bars=500 µm in A, 50 µm in B--E.

Figure 2Tenascin-X (Tn-X) positive vascular and leptomenigeal structures in monkey choroid plexus (CP), cerebellar cortex (CC), and medulla oblongata (MO). (A, B) Tn-X positive fibrous structures are clearly observed around blood vessels (asterisks) and within the connective tissue of CP in lateral ventricle (arrowheads). (C) Leptomeninges on the CC is strongly Tn-X positive (arrowheads). An arrow indicates Tn-X positive blood vessel. (D) Immunohistochemistry of tenascin -C in a neighboring section to the C. Tn-C positive leptomeninges is not observed in the CC (arrowheads). An arrow indicates Tn-C positive blood vessel, which is corresponding to the Tn-X positive blood vessel in C (arrow). E: Tn-X positive blood vessels are also observed in MO (arrows). EC: epithelial cell. Scale bars=50 µm.

In the fourth ventricle of mouse CP, Tn-X+ fibrils were restricted to the interstitial connective tissue and leptomeninges in the cerebellum, and no localization of Tn-C was observed ([Figure 3](#F3){ref-type="fig"}). These findings in the fourth ventricle were homologous in the monkeys described above.Tn-X localization in CP was consistently confirmed using immunohistochemical techniques in the lateral and fourth ventricles of monkeys and mice.

Figure 3Immunohistochemistry (IHC) of the tenascin-X (Tn-X) and tenascin-C (Tn-C) in mouse choroid plexus (CP) in fourth ventricle. (A) Low magnification of IHC of Tn-X in a coronal section at fourth ventricle level. One boxed region is re-photographed at higher magnification in B. (B, D) Tn-X positive fibrous structures are clearly observed within connective tissue of CP. Three arrowheads in B indicate Tn-X positive leptomeninges on PFl (paraflocculus). The panel D is photographed from an another section. (C, E) IHC of the Tn C in neighboring sections to the B and D. Tn C positive fibrous structures are not detected within the connective tissue of CP and leptomeninges. 4V: fourth ventricle, CC: cerebellar cortex, EC: epithelial cell, LR4V: lateral recess of 4V, MO: medulla oblongata. Scale bars=500 µm in A, 50 µm in B--E.

Discussion {#S3}
==========

We observed Tn-X localization in monkey CP in the present study. These findings were not previously reported in primates.

In mouse CP, we confirmed our previous reports of Tn-X localization in the lateral and fourth ventricles ([@R19]; present study). Tn-X localization in both species was confined to the interstitial connective tissue in CP. Tn-X directly binds to type I collagen and regulates type VI collagen for collagen fibrillogenesis ([@R24]; [@R27]). Collagen fibril in the CP connective tissue has been clearly observed in monkeys ([@R23]). Furthermore, the connective tissue of CP consists of type I collagen in mice ([@R25]) and of type VI collagen in humans ([@R28]). Because of the presence of collagen fibres and the role of Tn-X in collagen fibrillogenesis, Tn-X localization in CP has a functional role, although the type of collagen in monkey CP is unknown.

Tn-X deficiency is consistent with structural defects in human collagen. Patients with the connective tissue disorder EDS have been found to lack Tn-X ([@R8]); incomplete collagen fibere bundles are responsible for the symptoms. In addition to skin symptoms, vascular fragility and an abnormal perivascular structure have also been observed in EDS patients ([@R8]). In mouse and human blood vessels, Tn-X was confirmed by immunohistochemistry ([@R26]; [@R15]). Type VI collagen was observed in CP blood vessels in humans ([@R28]). These previous reports might support our finding of dense Tn-X localization around blood vessels in CP ([Figure 2](#F2){ref-type="fig"}).

Recently, Tn-X was shown to be significantly associated with schizophrenia in a single nucleotide polymorphism analysis in humans ([@R38]; [@R34]). Previous reports and our present findings possibly indicate a novel important role of Tn-X in the CNS. Tn-X interacts with vascular endothelial growth factor B (VEGF-B) and BDNF in endothelial cells and enhances the function of VEGF-B in endothelial cell proliferation ([@R17]), and Tn-X expression is stimulated by BDNF ([@R32]). In the nervous system, VEGF-B stimulates neurogenesis in the adult brain ([@R31]), and BDNF signalling is impaired in patients with schizophrenia ([@R7]). The secretion of BDNF in CP ([@R5]) and the strong expression of VEGF-B in CP of mouse embryo ([@R1]) suggest the possibility of an interaction between Tn-X and these two molecules in CP. To clarify this hypothesized interaction of Tn-X in CP, further investigation is needed in future studies.
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